Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.

Alcohol-related health issues surged during the COVID-19 pandemic, with a 17.6% rise in mortality, calling for enhanced ...

Jefferies analyst Brian Tanquilut upgraded Cardinal Health (CAH) to Buy from Hold with a price target of $150, up from $140. The firm thinks ...

Cardinal Health Inc. closed 5.65% below its 52-week high of $132.84, which the company achieved on January 30th.

President Donald Trump on Saturday signed executive orders imposing sweeping tariffs on the country’s three largest trading ...

Draped in Mexican and Salvadoran flags, roughly 1,000 demonstrators gathered near City Hall shortly before noon, blocking ...

TD Cowen raised the firm’s price target on Cardinal Health (CAH) to $150 from $144 and keeps a Buy rating on the shares. The firm said they ...

Valiquette also increased his earnings per share (EPS) estimates for Cardinal Health (NYSE:CAH), raising the fiscal year 2025 forecast from $7.90 to $7.95 and the fiscal year 2026 projection from $8 ...

Drug distributor Cardinal Health said on Thursday it may need to increase prices of some of its products if the proposed tariffs on Mexico go into effect, to counter increasing costs of manufacturing ...

Cardinal Health warned Thursday that if President Donald Trump follows through with threatened tariffs next month, higher ...

We recently published a list of Jim Cramer’s Latest Calls: 10 Stocks to Buy or Sell. In this article, we are going to take a ...

Videos circulating online used a clip from the parody site The Onion to falsely claim that Pope Francis has appointed Cardinal Luis Antonio Tagle as his successor Claim: Pope Francis has resigned ...